2000 |
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF. Osteoarthritis: new insights, I: the disease and its risk factors. Ann Intern Med. October 17, 2000;133(8):635-646. |
104 |
100 |
2008 |
Ritchie RO, Koester KJ, Ionova S, Yao W, Lane NE, Ager JW III. Measurement of the toughness of bone: a tutorial with special reference to small animal studies. Bone. November 2008;43(5):798-812. |
65 |
59 |
2020 |
Langsetmo L, Burghardt AJ, Schousboe JT, Cawthon PM, Cauley JA, Lane NE, Orwoll ES, Ensrud KE; Osteoporotic Fractures in Men (MrOS) Study Group. Objective measures of moderate to vigorous physical activity are associated with higher distal limb bone strength among elderly men. Bone. March 2020;132:115198. |
2 |
2 |
2020 |
Dai C, Jia J, Kot A, Liu X, Liu L, Jiang M, Lane NE, Wise BL, Yao W. Selective inhibition of progesterone receptor in osteochondral progenitor cells, but not in mature chondrocytes, modulated subchondral bone structures. Bone. March 2020;132:115196. |
0 |
0 |
2021 |
Frysz M, Baird D, Gregory JS, Aspden RM, Lane NE, Ohlsson C, Pettersson-Kymmer U, Karasik D, Tobias JH, Paternoster L. The influence of adult hip shape genetic variants on adolescent hip shape: findings from a population-based DXA study. Bone. February 2021;143:115792. |
0 |
0 |
2020 |
Taylor EA, Donnelly E, Yao X, Johnson ML, Amugongo SK, Kimmel DB, Lane NE. Sequential treatment of estrogen deficient, osteopenic rats with alendronate, parathyroid hormone (1–34), or raloxifene alters cortical bone mineral and matrix composition. Calcif Tiss Int. March 2020;106(3):303-314. |
6 |
5 |
1995 |
Kinney JH, Lane NE, Haupt DL. In vivo, three‐dimensional microscopy of trabecular bone. J Bone Miner Res. February 1995;10(2):264-270. |
57 |
51 |
1995 |
Lane NE, Thompson JM, Strewler GJ, Kinney JH. Intermittent treatment with human parathyroid hormone (hPTH[1‐34]) increased trabecular bone volume but not connectivity in osteopenic rats. J Bone Miner Res. October 1995;10(10):1470-1477. |
15 |
10 |
1998 |
Lane NE, Thompson JM, Haupt D, Kimmel DB, Modin G, Kinney JH. Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivo. J Bone Miner Res. February 1998;13(2):229-236. |
25 |
21 |
1998 |
Link TM, Majumdar S, Augat P, Lin JC, Newitt D, Lu Y, Lane NE, Genant HK. In vivo high resolution MRI of the calcaneus: differences in trabecular structure in osteoporosis patients. J Bone Miner Res. July 1998;13(7):1175-1182. |
30 |
26 |
2000 |
Kinney JH, Haupt DL, Balooch M, Ladd AJC, Ryaby JT, Lane NE. Three‐dimensional morphometry of the L6 vertebra in the ovariectomized rat model of osteoporosis: biomechanical implications. J Bone Miner Res. October 2000;15(10):1981-1991. |
25 |
24 |
2006 |
Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF. Glucocorticoid‐treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo‐treated or estrogen‐deficient mice. J Bone Miner Res. March 2006;21(3):466-476. |
50 |
40 |
2009 |
Orwoll ES, Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, Lane N, Hoffmann PR, Kopperdahl DL, Keaveny TM; Osteoporotic Fractures in Men (MrOS) Study Group. Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res. March 2009;24(3):475-483. |
48 |
40 |
2020 |
O'Keefe RJ, Tuan RS, Lane NE, Awad HA, Barry F, Bunnell BA, Colnot C, Drake MT, Drissi H, Dyment NA, Fortier LA, Guldberg RE, Kandel R, Little DG, Marshall MF, Mao JJ, Nakamura N, Proffen BL, Rodeo SA, Rosen V, Thomopoulos S, Schwarz EM, Serra R. American Society for Bone and Mineral Research‐Orthopaedic Research Society joint task force report on cell‐based therapies. J Bone Miner Res. January 2020;35(1):3-17. |
0 |
0 |
2020 |
Wei J, Lane NE, Bolster MB, Dubreuil M, Zeng C, Misra D, Lu N, Choi HK, Lei G, Zhang Y. Association of tramadol use with risk of hip fracture. J Bone Miner Res. April 2020;35(4):631-640. |
0 |
0 |
2021 |
Ensrud KE, Schousboe JT, Kats AM, Vo TN, Taylor BC, Cawthon PM, Cauley JA, Lane NE, Hoffman AR, Langsetmo L; Osteoporotic Fractures in Men (MrOS) Research Group. Height loss in old age and fracture risk among men in late life: a prospective cohort study. J Bone Miner Res. June 2021;36(6):1069-1076. |
1 |
1 |
2022 |
Alajlouni DA, Bliuc D, Tran TS, Blank RD, Cawthon PM, Ensrud KE, Lane NE, Orwoll ES, Cauley JA, Center JR. Muscle strength and physical performance are associated with risk of postfracture mortality but not subsequent fracture in men. J Bone Miner Res. August 2022;37(8):1571-1579. |
0 |
0 |
1994 |
Guilak F, Ratcliffe A, Lane N, Rosenwasser MP, Mow VC. Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritis. J Orthop Res. July 1994;12(4):474-484. |
86 |
54 |
2001 |
Laib A, Kumer JL, Majumdar S, Lane NE. The temporal changes of trabecular architecture in ovariectomized rats assessed by MicroCT. Osteoporos Int. November 2001;12(11):936-941. |
34 |
33 |
2002 |
Lane NE, Kumer JL, Majumdar S, Khan M, Lotz J, Stevens RE, Klein R, Phelps KV. The effects of synthetic conjugated estrogens, a (cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos Int. October 2002;13(10):816-823. |
4 |
4 |
2021 |
Swanson CM, Blatchford PJ, Stone KL, Cauley JA, Lane NE, Rogers-Soeder TS, Redline S, Bauer DC, Wright KP, Wierman ME, Kohrt WM, Orwoll ES; The Osteoporotic Fractures in Men (MrOS) Study. Sleep duration and bone health measures in older men. Osteoporos Int. March 2021;32(3):515-527. |
1 |
1 |
2021 |
Lane NE, Saag K, O’Neill TJ, Manion M, Shah R, Klause U, Eastell R. Correction to: real-world bone turnover marker use: impact on treatment decisions and fracture. Osteoporos Int. March 2021;32(3):609-609. |
0 |
0 |
2021 |
Lane NE, Saag K, O’Neill TJ, Manion M, Shah R, Klause U, Eastell R. Real-world bone turnover marker use: impact on treatment decisions and fracture [published correction appears in Osteoporos Int. March 2021;32(3):609-609]. Osteoporos Int. May 2021;32(5):831-840. |
0 |
0 |